| Literature DB >> 27217891 |
Marie Patrice Halle1, Linda Njonkam Toukep2, Samuel Ekane Nzuobontane3, Hermine Fouda Ebana4, Gregory Halle Ekane3, Eugene Belley Priso4.
Abstract
INTRODUCTION: Obstructive uropathy can lead to irreversible kidney damage. The etiology largely determined by the patient's age can be benign or malignant. This study aimed at determining the profile and outcome of patients with obstructive uropathy in Cameroon.Entities:
Keywords: Cameroon; Douala general hospital; Profile; obstructive uropathy; outcome
Mesh:
Year: 2016 PMID: 27217891 PMCID: PMC4862804 DOI: 10.11604/pamj.2016.23.67.8170
Source DB: PubMed Journal: Pan Afr Med J
General characteristics of patients with obstructive uropathy
| Variables | Total | Male(%) | Female (%) | P |
|---|---|---|---|---|
| Mean age (years±SD) | 50±18 | 50,7±20 | 48,6±14 | 0.43 |
| Hypertension | 39(17) | 30(19) | 9(13) | 0.24 |
| Diabetes Mellitus | 13(6) | 11(7) | 2(3) | 0.21 |
| Gout | 4(2) | 4(3) | (0) | 0.17 |
| Asthenia | 128(57) | 85(54) | 43(61) | 0.30 |
| Anorexia | 124(55) | 82(53) | 42(60) | 0.29 |
| Hiccup | 28(12) | 18(12) | 10(14) | 0.56 |
| Vomiting | 64(28) | 37(24) | 27(39) | |
| Insomnia | 39(17) | 25(16) | 14(20) | 0.40 |
| Cramps | 30(13) | 20(13) | 10(14) | 0.70 |
| Lower limb Oedema | 46(20) | 25(16) | 21(30) | |
| Dyspnea | 23(10) | 13(8) | 10(14) | 0.10 |
| Dysuria | 33(15) | 25(16) | 8(11) | 0.50 |
| Abdominal pain | 84(37) | 54(35) | 30(43) | 0.78 |
| Fever | 18(8) | 10 (6) | 8(11) | 0.10 |
| Macroscopichematuria | 15(7) | 9(6) | 6(6) | 0.43 |
| Urinary tract infection | 33(15) | 25(16) | 8(11) | 0.50 |
| Anuria | 33(15) | 15(10) | 18(26) | |
| Oliguria | 74(33) | 59(38) | 15(21) |
|
Biological parameters and etiologies of obstructive uropathy
| Variables | Total | Male(%) | Female(%) | P |
|---|---|---|---|---|
| Mean Heamoglobin (SD) | 8.40 (±2.4) | 8.5 (±2.2) | 8.1 (±2.8) | 0.31 |
| Mean Urea (SD) | 1.27(±1.07) | 1.25 (±1.07) | 1.31 (±1.07) | 0.71 |
| Mean Creatinine (SD) | 79.34 (±86) | 75.9 (±89) | 84.6 (±82) | 0.56 |
| Mean GFR(SD) | 10.3(±10.3) | 11.6 (±10) | 7.7 (±10) | 0.06 |
| Impaired renal fonction | 172(76) | 121(77.5) | 51(73) | 0.44 |
| Bladder Cancer | 10(4) | 7(5) | 3(4) | 0.70 |
| Congenital malformations | 12(5) | 11(7) | 1(1) | 0.08 |
| Retroperitoneal fibrosis | 3(1) | 1(0.6) | 2(3) | 0.17 |
Treatment and outcome of patients with obstructive uropathy
| Variables | Total | Male(%) | Female(%) | P |
|---|---|---|---|---|
| Urethral catherization | 44(19.6) | 28(24) | 6(9) |
|
| Double JJ | 43(19) | 27(17) | 16(23) | 0.32 |
| Suprapubic catherization | 14(6) | 12(8) | 2(3) | 0.16 |
| Nephrostomy | 1(0.4) | 0(0) | 1(1.4) | 0.13 |
| Indication for Dialysis | 94(41) | 62(40) | 32(46) | 0.20 |
| Dialysis done | 41(18) | 31(20) | 10(14) | 0.12 |
| Chemotherapy | 20 (9) | 3(2) | 17(24) | 0.07 |
| Radiotherapy | 12 (5) | 3(2) | 9(13) |
|
| Hormonotherapy | 18(8) | 18(12) | 0(0) |
|
| Alpha blockers | 21(9) | 21(13) | 0(0) |
|
| Analgesic | 86(39) | 58(37) | 28(40) | 0.094 |
| Total renal recovery | 63(28) | 49(31) | 14(20) | 0.07 |
| Partial renal recovery | 8(4) | 7(4) | 1(1) | 0.10 |
| No recovery | 12(5) | 10(6) | 2(3) | 0.14 |
| Lost to follow up | 94(41) | 69(44) | 29(41) | 0.69 |
| Death | 49(22) | 25(16) | 24(34) |
|
Factors associated to mortality of patients with obstructive uropathy
| Factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| No Death (N = 177) | Death(N = 49) | OR (95% CI) | OR (95% CI) | P | ||
| Age ≥ 50 ans | 93 | 33 | 2.6(0.8-8.2) | 0.09 | 1.1(0.25-4) | 0.89 |
| Female | 46 | 24 | 2.7(1.4-5.3) | 0.003 | 1.25(0.17-9) | 0.8 |
| Male | 131 | 25 | 0.36 (0.1-0.7) | 0.001 | ||
| Fever | 11 | 7 | 2.5(0.9-6.8) | 0.07 | ||
| Uremic syndrome | 53 | 39 | 9.1 (4.2-19.6) | 0.000 | 1.3(0.5-8) | 0.26 |
| Fluid overload | 18 | 20 | 6.1 (2.8-12.8) | 0.000 | 1.3(0.4-3) | 0.5 |
| Anuria | 15 | 18 | 6.2(2.9-13.7) | 0.000 | 2.2(0.6-7) | 0.18 |
| Urinary tract infection | 31 | 2 | 0.75(0.1-4.1) | 0.7 | ||
| prostatic cancer | 12 | 14 | 23.3(5.7-93.9) | 0.000 | 25(4-149) |
|
| Cervical Cancer | 14 | 21 | 8.7 (3.7-19.1) | 0.000 | 1.7(2-8.5) |
|
| Absence of Dialysis | 147 | 38 | 1.4(0.6-3) | 0.3 | 0.3(0.8-1.1) | 0.07 |
| Radiotherapy | 2 | 10 | 22.4 (4.7106.4) | 0.000 | 10(1.7-97) |
|
| Chemotherapy | 8 | 12 | 6.8 (2.6-17.9) | 0.000 | 1.2 (0.2-5) | 0.8 |